DAVID S. GRAYZEL Insider Profile

4 Followers
DAVID S. GRAYZEL, Director at Surface Oncology, holds 1.80M shares in Aerovate Therapeutics (Ticker: AVTE), holds 0.00 shares in Surface Oncology (Ticker: SURF), holds ― shares in Q32 Bio (Ticker: QTTB). Most recently, DAVID S. GRAYZEL Sold ― shares of Aerovate Therapeutics on Apr 11, 2024 for an estimated value of 334.48K.
tipranks
DAVID S. GRAYZEL

DAVID S. GRAYZEL
Surface Oncology (SURF)
Director

Ranked #26,912 out of 99,218 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

+12.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5M
100.00%
0.00%
A breakdown of DAVID S. GRAYZEL's holdings

Insider Roles

Aerovate Therapeutics
(AVTE)
Director
Q32 Bio
(QTTB)
Director
Roles that DAVID S. GRAYZEL holds in companies

Most Profitable Insider Trade

Stock:
Aerovate Therapeutics
(AVTE)
Rating:Informative Sell
Date:Apr 11, 2024 - Today
Return:+89.60%
The most profitable trade made by DAVID S. GRAYZEL

DAVID S. GRAYZEL's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SURF
Surface Oncology
Sep 08, 2023
Uninformative Sell
$0.00
Aerovate Therapeutics
Apr 11, 2024
Director
Informative Sell
334.48K
$4.89M
Q32 Bio
Director
List of latest transactions for each holding click on a transaction to see DAVID S. GRAYZEL's performance on stock

DAVID S. GRAYZEL insider profile FAQ

What is the percentage of profitable transactions made by DAVID S. GRAYZEL?
The percentage of profitable transactions made by DAVID S. GRAYZEL is 50%.
    What is the average return per transaction made by DAVID S. GRAYZEL?
    The average return per transaction made by DAVID S. GRAYZEL is 12.00%.
      What stocks does DAVID S. GRAYZEL hold?
      DAVID S. GRAYZEL holds: SURF, AVTE, QTTB stocks.
        What was DAVID S. GRAYZEL’s latest transaction?
        DAVID S. GRAYZEL latest transaction was an Informative Sell of $334.48K.
          What was DAVID S. GRAYZEL's most profitable transaction?
          DAVID S. GRAYZEL’s most profitable transaction was an Informative Sell of AVTE stock on April 11, 2024. The return on the trade was 89.60%.
            What is DAVID S. GRAYZEL's role in Surface Oncology?
            DAVID S. GRAYZEL's role in Surface Oncology is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.